Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Almost 25 years ago, the first mammalian transient receptor potential (TRP) channel was cloned and published. TRP channels now represent an extended family of 28 members fulfilling multiple roles in the living organism. Identified functions include control of body temperature, transmitter release, mineral homeostasis, chemical sensing, and survival mechanisms in a challenging environment. The TRP channel superfamily covers six families: TRPC with C for “canonical”, TRPA with A for “ankyrin”, TRPM with M for “melastatin”, TRPML with ML for “mucolipidin”, TRPP with P for “polycystin”, and TRPV with V for “vanilloid”. Over the last few years, new findings on TRP channels have confirmed their exceptional function as cellular sensors and effectors. This Special Book features a collection of 8 reviews and 7 original articles published in “Cells” summarizing the current state-of-the-art on TRP channel research, with a main focus on TRP channel activation, their physiological and pathophysiological function, and their roles as pharmacological targets for future therapeutic options.

n/a --- transient receptor potential channels --- photochromic ligands --- elementary immunology --- Purkinje cell --- EPSC --- substance P --- chemicals --- organ toxicity --- lymphocytes --- HSP70 --- physiology --- bioavailable --- inflammatory bowel disease --- platelets --- pollutants --- yeast --- regulatory T cells --- kinase --- Saccharomyces cerevisiae --- manganese --- cerebellum --- TRP channel --- NHERF --- inflammation --- nanoHPLC-ESI MS/MS --- TRPM7 --- chemical probes --- TRPM8 --- dorsal column nuclei --- TRPV2 --- TRPV3 --- calcitonin gene-related peptide --- TRPV1 --- ion channels --- transient receptor potential --- 2D gel electrophoresis --- MALDI-TOF MS(/MS) --- TRPV4 --- overproduction --- sulfur mustard --- oxidative stress --- graft versus host disease --- menthol --- topical --- chemosensor --- AP18 --- calcium signalling --- mucosal epithelium --- cuneate nucleus --- production platform --- TRPC channels --- ulcerative colitis --- channel structure --- xerostomia --- neutrophils --- cardiovascular system --- TRPC5 --- TRPC6 --- TRPC3 --- TRPC4 --- calcium signaling --- protein purification --- adipose tissue --- transient receptor potential (TRP) channels --- sodium --- TH17 --- diacylglycerol --- hypersensitivity --- TRPY1 --- GABAB --- HEK293 --- thrombosis --- ion channel --- TRPC --- pathophysiology --- SMAD --- toxicology --- endothelium --- calcium --- proteomics --- TRPA1 --- salivary glands --- TRP channels --- lipid mediators --- sensors --- radiation --- TRPM4 channel --- human medulla oblongata --- mGluR1 --- small molecules --- TRPC3 pharmacology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Fibroblast growth factor (FGF) signal transmission has an essential function in embryonic development and tissue repair, and is dysregulated in the vast majority of malignancies studied. The FGF signaling in the tumor cells is usually increased by autocrine and paracrine mechanisms and gives them a high growth potential, resistance to apoptosis, neoangiogenesis and metastasis, all essential parameters relevant for tumor progression. This makes FGFs, and their tyrosine kinase receptors FGFRs, valuable targets for therapeutic interventions. This book is a collection of 15 recent articles—both original work and reviews—that summarize the current research state effectively. The content covers FGF signaling aspects in gastric, skin, liver, esophageal cancer, melanoma, mesothelioma and glioblastoma, including one article that addresses the role of FGF in the tumor-microenvironment cross-talk. Several reports describe the development of compounds targeting FGFRs, their structure and interaction with the receptor molecules, and their effectivity in preclinical and clinical testing. In summary, the papers demonstrate the complexity of the topic, with various FGF ligands and receptors involved and the need for further research. They also present results that fuel hope that targeting cancer with dysfunctional FGF signaling can become a realistic treatment option.

Medicine --- FGFR4 --- FGF19 --- gene regulation --- cancer signaling --- anticancer --- FRS2 --- FGFR --- NVP-BGJ398 --- LY2874455 --- sarcoma --- cancer-associated fibroblasts --- GPER --- breast cancer --- estrogen --- FGFR1 --- FGF2 --- optogenetics --- ERK --- AKT --- receptor kinase --- neurite outgrowth --- HEK293 --- PC12 --- fibroblast growth factor receptors --- signaling --- receptor cross-talk --- coreceptor --- membrane proteins --- FGFR2 --- ERK1/2 --- phosphorylation --- serine --- negative feedback loop --- cancer --- prognosis --- HCC --- inhibitors --- FGF --- fibroblast growth factor --- autocrine signaling --- skin --- melanoma --- squamous and basal cell carcinoma --- seborrheic keratosis --- targeted therapy --- resistance --- structure --- kinase inhibitor --- gastric cancer --- monoclonal antibody --- small molecule --- FGFR2c --- autophagy --- keratinocyte --- MTOR --- JNK1 --- review --- malignant glioma --- brain cancer --- astrocytoma --- Sprouty proteins --- FGF-mediated signaling --- tumor suppressor --- tumor promoter --- malignant pleural mesothelioma --- overall survival --- immunohistochemistry --- infigratinib sensitivity --- FGF8 --- FGF18 --- adenocarcinoma of the esophagogastric junction --- neoadjuvant therapy --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Fibroblast growth factor (FGF) signal transmission has an essential function in embryonic development and tissue repair, and is dysregulated in the vast majority of malignancies studied. The FGF signaling in the tumor cells is usually increased by autocrine and paracrine mechanisms and gives them a high growth potential, resistance to apoptosis, neoangiogenesis and metastasis, all essential parameters relevant for tumor progression. This makes FGFs, and their tyrosine kinase receptors FGFRs, valuable targets for therapeutic interventions. This book is a collection of 15 recent articles—both original work and reviews—that summarize the current research state effectively. The content covers FGF signaling aspects in gastric, skin, liver, esophageal cancer, melanoma, mesothelioma and glioblastoma, including one article that addresses the role of FGF in the tumor-microenvironment cross-talk. Several reports describe the development of compounds targeting FGFRs, their structure and interaction with the receptor molecules, and their effectivity in preclinical and clinical testing. In summary, the papers demonstrate the complexity of the topic, with various FGF ligands and receptors involved and the need for further research. They also present results that fuel hope that targeting cancer with dysfunctional FGF signaling can become a realistic treatment option.

Medicine --- FGFR4 --- FGF19 --- gene regulation --- cancer signaling --- anticancer --- FRS2 --- FGFR --- NVP-BGJ398 --- LY2874455 --- sarcoma --- cancer-associated fibroblasts --- GPER --- breast cancer --- estrogen --- FGFR1 --- FGF2 --- optogenetics --- ERK --- AKT --- receptor kinase --- neurite outgrowth --- HEK293 --- PC12 --- fibroblast growth factor receptors --- signaling --- receptor cross-talk --- coreceptor --- membrane proteins --- FGFR2 --- ERK1/2 --- phosphorylation --- serine --- negative feedback loop --- cancer --- prognosis --- HCC --- inhibitors --- FGF --- fibroblast growth factor --- autocrine signaling --- skin --- melanoma --- squamous and basal cell carcinoma --- seborrheic keratosis --- targeted therapy --- resistance --- structure --- kinase inhibitor --- gastric cancer --- monoclonal antibody --- small molecule --- FGFR2c --- autophagy --- keratinocyte --- MTOR --- JNK1 --- review --- malignant glioma --- brain cancer --- astrocytoma --- Sprouty proteins --- FGF-mediated signaling --- tumor suppressor --- tumor promoter --- malignant pleural mesothelioma --- overall survival --- immunohistochemistry --- infigratinib sensitivity --- FGF8 --- FGF18 --- adenocarcinoma of the esophagogastric junction --- neoadjuvant therapy

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Advances in Nanomaterials in Biomedicine” provided a platform for more than 110 researchers from different countries to present their latest investigations in various fields of nanotechnology, new methods and nanomaterials intended for medical applications. Modern achievements in the field of nanoparticle-based diagnostics, drug delivery and the use of various nanomaterials in the treatment of diseases are presented in 11 original articles. The published reviews provide a comprehensive analysis of the current information on the use of nanomedicine in the treatment and diagnosis of cancer and liver fibrosis, in the field of solid tissue engineering and in drug delivery systems.

Medicine --- bone marrow-derived mesenchymal stromal cells --- rAAV vectors --- carbon dots --- SOX9 --- TGF-β --- cartilage repair --- silver nanoparticles --- Entada spiralis --- Ceiba pentandra --- antibacterial assay --- catalytic dye reduction --- osteoarthritis --- human articular cartilage --- polymeric micelles --- pro-inflammatory cytokines --- IL-1β --- TNF-α --- nanomaterials --- nanomedicine --- immunotherapy --- oncotherapy --- immune-checkpoint inhibitors --- immunogenic cell death --- nano-vaccines --- nano-conjugates --- immune response --- oxidative stress --- antioxidants --- nanoparticles --- biological nano-antioxidants --- gold nanoparticles --- radiation --- chemotherapy --- radiosensitizer --- drug delivery system --- chemoradiotherapy --- magnetoliposomes --- hydrogels --- magnetolipogels --- self-assembly --- fluorescence --- Förster resonance energy transfer --- polypropylenimine dendrimers --- polyethylenimines --- tyrosine-modified polypropylene-imines --- tyrosine-modified polyethlyenimines --- PPI-Y --- siRNA transfection --- polymeric nanoparticles --- carbosilane --- dendron --- triazine --- amphiphile --- vesicles --- pH-sensitive --- doxorubicin --- methotrexate --- leukaemia --- molecular ultrasound --- nanobubbles --- active targeting --- targeted microbubbles --- angiogenesis --- inflammation --- thrombosis --- clinical translation --- molecular imaging --- liver fibrosis --- diagnosis --- therapy --- theranostics --- targeted drug delivery --- lipid conjugates --- amphiphilic oligonucleotides --- phosphoryl guanidines --- nucleic acid delivery --- leukemia --- iron nanoparticles --- RNA-Seq --- cytotoxicity --- polymers --- biodegradable --- drug delivery --- pharmaceutical --- SQUID --- magnetic properties --- iron content --- magnetite nanoparticles --- superoxide --- aorta --- heart --- nano-biomaterials --- nanotechnology --- scaffolds --- hard tissue engineering --- AuNPs --- AuPEI-NPs --- AuBSA-NPs --- electron microscopy --- ultrastructure of HepG2 cells and spheroids --- ultrastructure of HEK293 cells and spheroids --- penetration of NPs into monolayer and spheroids --- gold nanostars --- photothermal therapy --- photoacoustic imaging --- computed tomography --- cancer --- theranostic agents --- biocompatible nanomaterials --- diagnostics --- nanocarriers --- tissue engineering